Former congressional staffer faces scrutiny in Medicare advantage leak

Sen. Chuck Grassley, R-Iowa, continues asking questions about a recent Medicare Advantage leak that reverberated through the stock market, while members of the Senate Finance Committee react to the Medicare funding reductions advanced by President Barack Obama.

Politico: Chuck Grassley Eyes Former Aide In Medicare Advantage Leak
A Washington law firm and a former congressional aide are facing scrutiny over a leak of sensitive details on Medicare Advantage payment rates that may have sparked hundreds of millions of dollars in stock trading on insurance companies before the information was made public. Sen. Chuck Grassley (R-Iowa) is questioning whether a lobbyist at Greenberg Traurig, a K Street law firm, tipped off Height Securities, a political intelligence firm, regarding a soon-to-be-announced increase in Medicare Advantage rates. Height quickly put out an investor alert before the markets closed on April 1 -- and before the government announced it was raising the rates after earlier proposing the largest cuts in the history of Medicare Advantage (Millman, 4/17).

Kaiser Health News: Capsules: The Medicare Budget Cuts No One Likes
Just in case the Obama administration didn't know it already, cutting Medicare is hard to do. During a Senate Finance Committee hearing Wednesday on President Barack Obama's fiscal 2014 budget, Democrats and Republicans proved that. Both Republicans, who have sought major changes to entitlements, and Democrats, who have vowed to preserve the programs, expressed concerns with the president's blueprint (Carey, 4/18).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
People with cerebral amyloid angiopathy more likely to develop dementia